Fig. 3From: Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PETPatlak Ki values, representing irreversible uptake, of biopsy-proven target-negative and target-positive tumours from the 89Zr-anti-CD20 study (A) and the 89Zr-CEA-IL2v study (B). Median and interquartile range values are presented in blackBack to article page